Concepts in Malignant Haematology and Acute Leukaemia Flashcards

1
Q

How can mature cells be identified?

A

Morphology
Cell surface antigens
Enzyme expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How can normal progenitors/stem cells?

A

Cell surface antigens
Cell culture assays
Animal models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens in malignant haemopoiesis?

A

Increased numbers f often dysfunctional cells

Possible loss of normal haemopoietic reserve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name 4 things that may be present in a malignant haemopoiesis?

A

Increased proliferation
Lack of differentiation
Lack of maturation
Lack of apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the difference between Driver’s and Passenger mutations?

A

Driver’s confer growth advantage

Passenger ones do not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Is haemopoiesis usually polyclonal or monoclonal?

A

Polyclonal, unless malignnant, in which case it is monoclonal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can the cancers be classified?

A

Acute or Chronic

Lymphoid or Myeloid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which is more aggressive, high grade or low grade lymphoma?

A

High grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where are myeloma’s?

A

Plasma cell malignancy in marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where is chronic lymphocytic leukaemia?

A

Blood and Bone marrow and lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe Acute Lymphoblastic Leukaemia? (ALL)

A

Malignant disease of lymphocytes

Most common childhood cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is ALL characterised?

A

Marrow failure (anaemia, infections, bleeding)
High WCC + involuntary of extra-medullary areas e.g. CNS
Lymph nodes causing venous obstruction
Bone pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Acute Myeloid Leukaemia? (AML)

A

More common in elderly

May be de novo or secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the presentation in AML?

A

Similar to ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do you investigate acute leukaemia?

A
Blood count and film
Coagulation screen
Bone marrow aspirate
Morphology
Immunophenotype
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does acute leukaemia look on blood film?

A

Reduction in normal cells
Presence of abnormal cells
Blasts have a high nuclear:cytoplasmic ratio

17
Q

Even when ALL and ALL cells look alike, what can be used to tell the difference between them?

A

Lineage-associated proteins that are expressed

18
Q

What is trephine and why is it useful?

A

It’s a piece of bone

Enables better assessment of cellularity and helpful when aspirate sub-optimal

19
Q

What is the treatment of ALL?

A

Multi-agent chemo
Can last up to 2-3 years
Varying intensity

20
Q

How is AML treated?

A

Multi-agent chemo
Intensive
2-4 cycles of chemo (5-10 days of chemo) with 2-4 weeks recovery
Prolonged hospitalisation

21
Q

What is the Hickman line?

A

Chemo is administered via a hickman line.

A central venous catheter that sits near the right venous angle

22
Q

What 3 issues can occur due to marrow suppression?

A

Anaemia
Neutropenia - infections
Thrombocytopenia - bleeding, purpura, petechiae

23
Q

What are complications of chemo?

A
Nausea and Vomiting
Hair loss
Liver/renal failure
Tumour lysis syndrome
Infection
Loss of fertility
Cardiomyopathy with anthracyclines
24
Q

What is the cure rate for childhood ALL?

A

85-90%

25
Q

What is the cure rate for adult ALL?

A

30-40%

26
Q

What is the cure rate for adult AML?

A

40-50%

In some subtypes = 90%

27
Q

What is the cure rate for adult AML?

A

<10%

28
Q

What can potentially be curative?

A

Allogeneic stem cell transplantation